Physician

Amir Saffarian, M.D.

According to 2025 Medicare claims, Amir Saffarian, M.D. (NPI: 1861590176) practices urology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from San Benito, CA. This provider's primary affiliated billing organization is AMIR SAFFARIAN, M.D., INC. (NPI: 1104057298; TIN: 270647218) and primary practice location at 95037-8103.

Saffarian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 773 traditional Medicare patients, billed 13,680 HCPCS/CPT codes, and received $1,130,957 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 2,436 prescription claims across 649 beneficiaries totaling $112,225 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 21 claims. Open Payments data shows 45 records totaling $4,160. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $284,201 to $1,130,957. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	392	2,669	$284,201
2016	434	4,349	$352,992
2017	492	4,273	$367,541
2018	531	4,682	$514,872
2019	518	5,123	$687,719
2020	497	4,797	$589,503
2021	575	6,555	$744,808
2022	631	7,675	$1,023,827
2023	651	8,581	$846,357
2024	773	13,680	$1,130,957

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	263	970	$80,194
2016	280	1,098	$76,528
2017	331	1,290	$81,009
2018	365	1,362	$84,932
2019	374	1,376	$64,421
2020	395	1,556	$67,049
2021	461	1,916	$55,846
2022	509	2,030	$75,821
2023	562	2,052	$105,383
2024	649	2,436	$112,225

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$5,349
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$13,344
2020	N/R	39	$20,686
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	21	$4,405

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	162	170	$256
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	221	221	$152
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	446	677	$115
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	331	448	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	604	1,121	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	60	3,600	$54,884
Gemtesa	Vibegron	15	1,071	$16,756
Tamsulosin Hcl	Tamsulosin Hcl	714	59,468	$10,776
Oxybutynin Chloride Er	Oxybutynin Chloride	240	17,992	$7,470
Finasteride	Finasteride	427	36,609	$5,476

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	21	$4,405

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$4,160	Teleflex LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amir Saffarian, M.D.?

Tedicare shows public-source Medicare data for Amir Saffarian, M.D. (NPI 1861590176), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amir Saffarian, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amir Saffarian, M.D.?

Amir Saffarian, M.D. is linked to AMIR SAFFARIAN, M.D., INC. (billing NPI 1104057298) in the available physician profile data.

Does Amir Saffarian, M.D. have Open Payments data?

Amir Saffarian, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.